STERIS announces completion of libertyville, illinois expansion to include x-ray processing

June 24, 2024

  • Supports medical device and pharmaceutical manufacturing with additional irradiation processing capacity
  • Provides a comprehensive technology-neutral radiation service offering at the Libertyville campus

June 24, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completed expansion of its existing Libertyville II, Illinois gamma processing facility to include X-ray processing.

The expansion of the Libertyville II facility furthers our commitment of ensuring patient safety through a technology-neutral service offering that includes radiation and gas processing options, now and well into the future.

In addition to X-ray and gamma processing at Libertyville II, our Libertyville campus includes a second gamma processing facility, an on-site microbiological laboratory, our Radiation Technology Center, and is home to our Radiation TechTeam® technical professionals. The combination of a dedicated technology center, technical support for radiation processing, and laboratory services in one location results in a seamless transfer of validation and dose work into our production processing locations.

Increased demand in medical device and pharmaceutical manufacturing has accelerated our plans for global expansion. The addition of accelerator-based radiation processing options throughout our global network allows us to support Customers with both routine services and processing redundancy.

STERIS announces completion of libertyville illinois expansion to include x ray processing
Related Posts
Exterior View of STERIS Facility in Batu Kawan, Malaysia
May 1, 2025

1st May, 2025 As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce a new ethylene oxide (EO) processing facility in Batu Kawan industrial Park in Penang, Malaysia.

202310-LibertyvilleIL-Lab-5
March 28, 2025
March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
New-Swindon-Lab-1-600x600
February 5, 2025
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
STERIS is pleased to announce our brooklyn park mn usa laboratory now offers bacteria
January 10, 2025
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.